← FDA DRUG APPROVALS

FDA ANDA · ANDA065092

RANICLOR

Sponsor: RANBAXY LABS LTD

APPLICATION
ANDA065092
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-22
LATEST ACTION
2003-12-22
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

RANICLORDiscontinued
CEFACLOR EQ 125MG BASE · TABLET, CHEWABLE · ORAL
RANICLORDiscontinued
CEFACLOR EQ 375MG BASE · TABLET, CHEWABLE · ORAL
RANICLORDiscontinued
CEFACLOR EQ 187MG BASE · TABLET, CHEWABLE · ORAL
RANICLORDiscontinued
CEFACLOR EQ 250MG BASE · TABLET, CHEWABLE · ORAL

Approval history

2003-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →